ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint747,212 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical companyStansQanatpharma AG
Qanatpharma AG Logo
Verified· 2 sourcesTrust Score
Summary

About the company

Qanatpharma AG is a biopharmaceutical company developing therapies that target resistance artery dysfunction and the microcirculation. Its activities include research, drug discovery and clinical programs for cardiovascular and cerebrovascular conditions.

AI-generated
Offering

Products & services

Industry:
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

Qanatpharma AG

Pharmaceutical company
✓ Offered4
Research platform (ARTERIOME)
End-to-end discovery and translation platform for resistance artery research, with bioengineering, multimodal phenotyping, omics analyses, AI-supported target identification and translational research design.
Drug development (GENESiS)
Drug-discovery program for first-in-class small-molecule and biologic solutions to restore resistance artery function, with generative-AI-driven lead discovery and a partner consortium.
Clinical proof-of-concept studies
Proof-of-concept studies for clinical testing of microvascular therapies, including randomized, double-blind Phase II studies, MRI and cognitive tests, and recruitment in Toronto.
Therapy development for cerebrovascular diseases
Development of therapies for subarachnoid hemorrhage, delayed cerebral ischemia and cognitive impairment in heart failure, based on restoring cerebral autoregulation.
Trust & reputation

ranQ Trust Score of Qanatpharma AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 54% · As of November 2026

Without public customer reviews the score stays capped.

Qanatpharma AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
Qanatpharma AG scores 76.5 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.70.212%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
Qanatpharma AG scores 83.3 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).83.322%
Qanatpharma AG scores 37.1 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.37.14%
  • Media authority: No data point — the criterion is taken out of the weighting and does not lower the score.—4%
Qualifications+0.00

Qanatpharma AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 54%, so the score is backed by part of the criteria. As of November 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Knowledge

No knowledge articles yet

Once Qanatpharma AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

Qanatpharma AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank Qanatpharma AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of Qanatpharma AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Alter Postplatz 2
6370 Stans

At a glance

Legal form
Corporation
UID
CHE-336.262.668
Founded
2020 · 6 years
Last commercial register change
April 24, 2023
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    MP
    M&P Pharma AG
    Emmetten
    SH
    STELLAPLANT HOLDING AG
    Hergiswil Nw
    PD
    Pharmaland DC AG
    Buochs
    PA
    Pearsceuticals AG
    Hergiswil Nw
    RA
    RUBIMED AG
    Hergiswil Nw
    RS
    Roivant Sciences GmbH
    Basel
    RP
    Rhizen Pharmaceuticals AG
    Basel
    CB
    C Bertozzi Services
    Schlieren